Exhibitors Database 2019
EFORT invites you to browse through the Exhibitors Database of the 20th EFORT Annual Congress Lisbon 2019 which represents those exhibitors that have already committed to and confirmed their presence at the 2019 EFORT Congress to be held in Lisbon, Portugal, from 05 to 07 June 2019.
The following search tool will give you the possibility to look for a particular exhibitor, find their booth number in the exhibition area and contact your industry partner.
EFORT Exhibitors & Industry Database
Heraeus Medical GmbH
Heraeus Medical brings value to the patient, the healthcare professional and the health care system by providing solutions for the fixation of joint implants, driving infection management and by pioneering regenerative treatments for bone, cartilage and soft tissue
Orthopaedic pain should not be a lifetime sentence.
Treatments for muscoskeletal degeneration are highly specialized, costly and resources are restricted. Patients have to live with pain and loss of ability for long periods of time. Therefore Heraeus has embraced this challenge and will develop effective, safe and affordable orthobiologic solutions.
Preventing infections from the outset - trust PALACOS
PALACOS® bone cement is probably the best-known product from Heraeus and considered the Gold Standard for joint arthroplasty. For decades PALACOS® bone cement with Gentamicin allows for effective infection prophylaxis through local application of antibiotics. Recent data from the National Joint Registry (NJR) demonstrate that PALACOS® R+G has a significantly lower revision rate in comparison to all other cement brands in hip and knee replacements.
PALAMIX – the next generation: Mixing and collecting under vacuum
PALAMIX® is the secret behind optimal processing of Heraeus bone cements.
The new PALAMIX® vacuum mixing system makes vacuum mixing and application of bone cement more convenient: Both the mixing of the components and the collection of the bone cement is carried out under vacuum.
Infection Management – Managing implant and tissue infections
The successful treatment of periprosthetic joint infections (PJI) necessitates a targeted approach with accurate and exact diagnostic results to ensure an effective antibiotic use and a sustainable infect eradication. Heraeus with its extensive experience in the field of therapeutic support with local antibiotics, provides high quality training and supports international knowledge projects on PJI.
|Arthroplasty patients with high risk for infection – do we need to change our clinical practice?||Thursday, 6 June 2019, 13.00 - 14.30|